BENDAMUSTINE PLUS RITUXIMAB IN PATIENTS WITH RELAPSED OR REFRACTORY WALDENSTROM'S MACROGLOBULINEMIA (WM)

被引：0
|
作者：
Improta, S. [1 ]
Villa, M. [1 ]
Gagliardi, A. [1 ]
Lucania, A. [1 ]
Della Cioppa, P. [1 ]
Esposito, M. [1 ]
Mastrullo, L. [1 ]
机构：
[1] PO San Gennaro ASL Napoli 1 Ctr, UOC Ematol, Naples, Italy
来源：
HAEMATOLOGICA | 2013年 / 98卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
B1617
引用
收藏
页码：638 / 638
页数：1
相关论文
共 50 条
  • [21] Phase II Trial of Weekly Bortezomib in Combination with Rituximab in Relapsed or Relapsed/Refractory Waldenstrom's Macroglobulinemia.
    Ghobrial, Irene M.
    Hong, Fangxin
    Padmanabhan, Swaminathan
    Badros, Ashraf Z.
    Rourke, Meghan
    Leduc, Renee
    Chuma, Stacey
    Kunsman, Janet
    Warren, Diane
    Harris, Brianna
    Sam, Amy
    Anderson, Kenneth C.
    Richardson, Paul
    Treon, Steven
    Weller, Edie
    Matous, Jeffrey
    BLOOD, 2009, 114 (22) : 1067 - 1067
  • [22] Bendamustine and rituximab (BR) versus dexamethasone, rituximab, and cyclophosphamide (DRC) in patients with Waldenstrom macroglobulinemia
    Paludo, Jonas
    Abeykoon, Jithma P.
    Shreders, Amanda
    Ansell, Stephen M.
    Kumar, Shaji
    Ailawadhi, Sikander
    King, Rebecca L.
    Koehler, Amber B.
    Reeder, Craig B.
    Buadi, Francis K.
    Dispenzieri, Angela
    Lacy, Martha Q.
    Dingli, David
    Witzig, Thomas E.
    Go, Ronald S.
    Gonsalves, Wilson I.
    Kourelis, Taxiarchis
    Warsame, Rahma
    Leung, Nelson
    Habermann, Thomas M.
    Hayman, Suzanne
    Lin, Yi
    Kyle, Robert A.
    Rajkumar, S. Vincent
    Gertz, Morie A.
    Kapoor, Prashant
    ANNALS OF HEMATOLOGY, 2018, 97 (08) : 1417 - 1425
  • [23] CHOP plus Rituximab therapy in Waldenstrom's macroglobulinemia
    Treon, SP
    Hunter, Z
    Branagan, AR
    CLINICAL LYMPHOMA, 2005, 5 (04): : 273 - 277
  • [24] Treatment of relapsed and refractory Waldenstrom Macroglobulinemia
    Amaador, Karima
    Kersten, Marie J.
    Minnema, Monique C.
    Vos, Josephine M., I
    LEUKEMIA & LYMPHOMA, 2023, 64 (01) : 30 - 41
  • [25] Phase II trial of combination of bortezomib and rituximab in relapsed and/or refractory Waldenstrom macroglobulinemia
    Ghobrial, I. M.
    Matous, J.
    Padmanabhan, S.
    Badros, A.
    Chuma, S.
    Leduc, R.
    Rourke, M.
    Kunsman, J.
    Harris, B.
    Warren, D.
    Richardson, P.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [26] Phase II Trial of Combination of Bortezomib and Rituximab in Relapsed and/or Refractory Waldenstrom Macroglobulinemia
    Ghobrial, Irene M.
    Matous, Jeffrey
    Padmanabhan, Swaminathan
    Badros, Ashraf
    Schlossman, Robert
    Chuma, Stacey
    Leduc, Renee
    Nelson, Marybeth
    O'Connor, Kelly
    Sam, Amy
    Harris, Brianna
    Soumerai, Jacob
    Warren, Diane
    Birner, Ann
    Munshi, Nikhil
    Treon, Steven P.
    Anderson, Kenneth C.
    Richardson, Paul
    BLOOD, 2008, 112 (11) : 308 - 309
  • [27] Phase II Trial of Weekly Bortezomib in Combination With Rituximab in Relapsed or Relapsed and Refractory Waldenstrom Macroglobulinemia
    Ghobrial, Irene M.
    Hong, Fangxin
    Padmanabhan, Swaminathan
    Badros, Ashraf
    Rourke, Meghan
    Leduc, Renee
    Chuma, Stacey
    Kunsman, Janet
    Warren, Diane
    Harris, Brianna
    Sam, Amy
    Anderson, Kenneth C.
    Richardson, Paul G.
    Treon, Steven P.
    Weller, Edie
    Matous, Jeffrey
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (08) : 1422 - 1428
  • [28] BENDAMUSTINE AND RITUXIMAB COMBINATION IS SAFE AND EFFECTIVE AS SALVAGE REGIMEN IN WALDENSTROM'S MACROGLOBULINEMIA
    Tedeschi, A.
    Franceschetti, S.
    Benevolo, G.
    Varettoni, M.
    Motta, M.
    Zaja, F.
    Barate, C.
    Gini, G.
    Goldaniga, M. C.
    Visco, C.
    Petrizzi, V. Belsito
    Picardi, P.
    Frustaci, A. M.
    Riccomagno, P.
    Casaluci, G. Margiotta
    Orsucci, L.
    Vitolo, U.
    Gaidano, G.
    Morra, E.
    HAEMATOLOGICA, 2014, 99 : 226 - 226
  • [29] Bendamustine and Rituximab Combination Is Safe and Effective As Salvage Regimen in Waldenstrom's Macroglobulinemia
    Tedeschi, Alessandra
    Benevolo, Giulia
    Margiotta, Gloria Casaluci
    Ferrero, Simone
    Picardi, Paola
    Varettoni, Marzia
    Barate, Claudia
    Motta, Marina
    Gini, Guido
    Goldaniga, Maria Cecilia
    Visco, Carlo
    Zaja, Francesco
    Petrizzi, Valeria Belsito
    Ravelli, Erika
    Gentile, Massimo
    Urbano, Marina
    Franceschetti, Silvia
    Orsucci, Lorella
    Frustaci, Annamaria
    Riccomagno, Paola
    Ghione, Paola
    Gaidano, Gianluca
    Vitolo, Umberto
    Morra, Enrica
    BLOOD, 2014, 124 (21)
  • [30] Clinical and Molecular Results of the Phase II Brb (Bendamustine, Rituximab and Bortezomib) Trial of the Fondazione Italiana Linfomi (FIL) for Relapsed/Refractory Waldenstrom Macroglobulinemia Patients
    Benevolo, Giulia
    Ferrero, Simone
    Andriani, Alessandro
    Castiglione, Anna
    Baraldi, Anna
    Boccomini, Carola
    Cabras, Maria Giuseppina
    Califano, Catello
    Cavallo, Federica
    Conconi, Annarita
    Curreli, Luigi
    Drandi, Daniela
    Gaidano, Gianluca
    Felici, Stefano
    Ferrante, Martina
    Mannina, Donato
    Merli, Michele
    Molinari, Anna Lia
    Musto, Pellegrino
    Musuraca, Gerardo
    Rossi, Francesca Gaia
    Sartori, Roberto
    Tani, Monica
    Varettoni, Marzia
    Vitolo, Umberto
    Orsucci, Lorella
    BLOOD, 2018, 132
12345